Patents for C07F 5 - Compounds containing elements of the 3rd group of the periodic system (13,801)
05/2008
05/20/2008US7375217 Reduction of the benzoquinone moiety to form a hydroquinone, and salt formation, producing 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents
05/15/2008WO2008056290A1 Use of arylboronic acids in protein labelling
05/15/2008WO2008055859A1 Dialkylborane amine complexes
05/15/2008US20080114136 Metal Complex Containing Tridentate Ligand, and Polymerization Catalyst Comprising the Same
05/15/2008US20080112884 Administering to a patient a contrast agent (pyridimifen, fenazaquin) which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging
05/15/2008US20080112866 Functionalized ionic liquids, and methods of use thereof
05/15/2008CA2668732A1 Dialkylborane amine complexes
05/14/2008EP1921081A1 Use of arylboronic acids in protein labelling
05/14/2008EP1921061A1 Metal-containing compound, process for producing the same, metal-containing thin film, and method of forming the same
05/14/2008EP1919485A1 Methods of preparing hetercyclic boronic acids and derivatives thereof
05/13/2008US7371729 Boronic acid salts useful in parenteral formulations
05/08/2008WO2008053935A1 Cyclic siloxane compound, organic electroluminescent element, and use thereof
05/08/2008WO2008053360A2 Albumin binding molecules and uses thereof
05/08/2008CA2669726A1 Albumin binding molecules and uses thereof
05/07/2008EP1917271A2 A microoptic glucose detector
05/07/2008EP1917228A1 Mesoporous metal-organic framework
05/07/2008CN101175761A Method for producing 2-formylfuran-4-boronic
05/07/2008CN101172986A Organic light emitting materials with anionic ligand
05/07/2008CN100386331C Polymerization catalyst activator and its use in a polymerization process
05/06/2008US7368616 Method for the production of monomers useful in the manufacture of semiconductive polymers
05/06/2008US7368100 Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same
05/06/2008CA2274648C Polymerizable biaryls, process for their preparation and their use
05/01/2008US20080102534 Unsaturated Dipyrromethene-Boron Borocarbons
05/01/2008US20080102313 Atomic layer chemical vapor deposition of hybrid organic inorganic coatings comprised of such as aluminium benzene oxides; optical properties
05/01/2008US20080102279 Borate and Near-Infrared Ray Absorption Material
05/01/2008US20080102028 converting 2,2-dimethyloxirane to 2-methoxyisobutanol, and converting 2-methoxyisobutanol to 2-methoxyisobutylisonitrile; used in the preparation of technetium (99mTc) Sestamibi
05/01/2008US20080102026 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
04/2008
04/30/2008EP1915400A2 Catalysts for radical polymerization
04/30/2008EP1915382A2 Hepatitis c serine protease inhibitors and uses therefor
04/30/2008EP1915381A1 Boron compounds useful in bnct
04/30/2008EP1506168B1 Gelling agents
04/30/2008CN101171320A 有机电致发光器件 Organic electroluminescent devices
04/30/2008CN101171222A Terrylene and quaterrylene derivatives
04/30/2008CN101168546A Method for preparing Lithium bis(oxalate)borate
04/30/2008CN101168499A Synthesis method for aluminum carboxylate nucleater without acidic byproduct
04/30/2008CN100384962C Preparation method of rare earth compound nano-particle
04/30/2008CN100384892C Catalysts for olefin polymerization
04/29/2008US7365212 Metal borohydride, a Lewis base and an inorganic acid ester are brought together and an optically active amino alcohol and optionally a halide are then added; complex that is useful as a catalyst in asymmetric reduction reactions, to synthesize chiral alcohols or chiral amines
04/29/2008US7365201 Process for the preparation of the boron difluoride chelate of quinolone-3-carboxylic acid
04/29/2008US7365198 Silyl compound, light emitting material, and organic light emitting device using the same
04/24/2008WO2008046950A1 P,s-type bidentate chiral ligands and use thereof in the pauson-khand reaction
04/24/2008US20080095702 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
04/24/2008US20080095697 Forming a metal oxide sol by hydrolyzing and condensing an alkoxy metal or silicon compound in a solvent and inthe presence of an inorganic or organic particle; drying, heating and crushing the metal oxide sol; antiagglomerants; uniform dispersion; vehicle brake pads and linings and industrial machinery
04/24/2008DE102006049821A1 New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues
04/23/2008EP1913005A1 Fluorophenylborates and their use as activators in catalyst systems for olefin polymerization
04/23/2008EP1421828A4 Organic light emitting devices having carrier transporting layers comprising metal complexes
04/22/2008US7361664 For therapy of cancer, hyperparathyroidism, vascular calcification, bone disease, renal failure or kidney stones, psoriasis
04/22/2008US7361647 hydroquinone derivatives of the Geldanamycin family; heat shock protein (chaperone) Hsp90 antagonist; improved solubility and air stability; antiproliferative and anticarcinogenic agents
04/22/2008CA2278130C Group 5 transition metal compounds
04/17/2008WO2008044443A1 Gadolinium compound and contrast medium for mri
04/17/2008US20080090132 Proton Conducting Mediums for Electrochemical Devices and Electrochemical Devices Comprising the Same
04/16/2008EP1911074A2 Beta-diketiminate ligand sources and metal-containing compounds thereof, and systems and methods including same
04/16/2008EP1910277A1 Quadratic acid derivatives in the form of a protein kinase inhibitors
04/16/2008EP1594855A4 Signalling compounds for use in methods of detecting hydrogen peroxide
04/16/2008CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
04/16/2008CN100381418C Gelling agents
04/15/2008US7358358 includes (1) beta -(10-phenothiazyl)propoxy phosphonic acid; (2) beta -(10-phenothiazyl)propyl-phosphonic acid; and (3) beta -(10-phenothiazyl)propionate phosphonic acid; p-type redox promoters and redox chromophores
04/15/2008US7358343 Endohedral metallofullerene derivatives
04/15/2008CA2176525C Fluorescent compounds
04/10/2008WO2008041123A1 Photoactive compounds
04/10/2008US20080086013 Contacting alkyne substrate and an aluminum compound, an additive: substituted or unsubstituted alkylaluminoxane, primary or secondary alkyl alcohols and alkyl thiols, in the presence of a carboaluminatination bis/cyclopentadieneyl/zrcl2 type catalyst to form vinylalan
04/09/2008EP1907541A2 Methods for the electromanipulation of cells in order to modify the membrane permeability of said cells with the aid of lipophilic ions as a medium additive
04/09/2008CN100380706C Organic element for electric light emitting device
04/09/2008CN100380236C Electrograph photosensitive element, electrograph device and processing case
04/09/2008CN100379745C Improved precursors for chemical vapour deposition
04/08/2008US7355058 For use in polymerization catalyst systems; mixing aluminoxane andhalogenation agent in an inert, anhydrous environment
04/08/2008US7354952 Pharmaceutical gallium compositions and methods
04/03/2008WO2008039312A2 Bootstrap synthesis of boranes
04/03/2008DE102006043254A1 Verfahren zur Herstellung von Dimethylaminboran A process for producing dimethylamine
04/03/2008CA2663684A1 Bootstrap synthesis of boranes
04/02/2008EP1904460A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
04/02/2008EP1904057A2 Methods of treatment using hydroquinone ansamycins
04/02/2008EP1720887B1 Aqueous-based adhesive for bonding low surface energy substrates
04/02/2008CN101155803A Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate
04/02/2008CN101153046A Boronation phosphoryl phosphor hydrazide ester, preparing method and application of the same
04/01/2008US7351728 peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis
04/01/2008US7351678 Using nitrogenous aluminium organyl complexes as co-catalysts in heterogeneous polymerisation reactions of propene
03/2008
03/27/2008WO2008035533A1 Optical filter containing squarylium dye-metal complex compound and filter for display panel using the same
03/27/2008WO2006102604A3 Topical formulations of borinic acid antibodies and their methods of use
03/27/2008US20080076943 4-(Hydroxymethyl)-2,6-dimethoxyphenylboronic acid chemical intermediate for preparing corticotropin-releasing factor receptor antagonists
03/27/2008DE102007042943A1 New titanium, zirconium and hafnium alkenoxides useful for forming thin films, e.g. on electronic or optical components
03/26/2008EP1903618A1 Method for producing trialkyl gallium
03/26/2008EP1903047A1 Method for producing trihydrocarbylborane
03/26/2008CN101151345A Organic EL material, organic EL element employing the same, and process for producing organic EL element
03/25/2008US7348445 Dimethylethyl ethylenediamine dimethylaluminum; liquid at room temperature, adequate vapor pressure, thermal stability; vapor deposition
03/25/2008US7348428 Triarylamine containing monomers for optoelectronic devices
03/25/2008US7348350 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesirable microorganisms
03/20/2008WO2008032793A1 Lithium salt
03/20/2008WO2008032702A1 Fluoroboron compound having aromatic ring or salt thereof, and process for production of compound having cyclic ether-fused aromatic ring by using the same
03/20/2008WO2008032189A1 Method for producing dimethylamine borane
03/20/2008US20080071093 Forming, purification of dipyrromethane and porphrin ; condensation, oxidation, cyclization
03/20/2008US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide
03/20/2008US20080069788 Dissolving an aluminum metal with hydrohalic acid and an organic acid; antipersperant
03/20/2008US20080069747 Destruction of Organics in Bayer Process Streams
03/19/2008EP1899358A2 Novel p-chiral functionalised arylphosphines and derivatives, the preparation and use thereof for asymmetrical catalysis
03/19/2008EP1899317A2 Enantiomers of n,n-dimethyl-3-(2-thienyl)-3-hydroxypropanamine borane as intermediates in the synthesis of duloxetine
03/19/2008EP1898899A1 Inhibitors of fibroblast activation protein alpha
03/19/2008CN101143876A Method for preparing melamine phosphate (borate) fire retardant
03/13/2008WO2008029670A1 Organic electroluminescent device material and organic electroluminescent device
03/13/2008WO2007143328A3 Single-site catalyst activators, processes for making same, and use thereof in catalysts and polymerization of olefins
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 139